Prior studies suggest an association between Vitamin K antagonists (VKA) and cerebral microbleeds (CMBs); less is known about nonvitamin K oral anticoagulants (NOACs). In this observational study we describe CMB profiles in a multicenter cohort of 89 anticoagulation-related intracerebral hemorrhage (ICH) patients. CMB prevalence was 51% (52% in VKA-ICH, 48% in NOAC-ICH). NOAC-ICH patients had lower median CMB count [2(IQR:1-3) vs. 7(4-11); P < 0.001]; ≥5 CMBs were less prevalent in NOAC-ICH (4% vs. 31%, P = 0.006). This inverse association between NOAC exposure and high CMB count persisted in multivariable logistic regression models adjusting for potential confounders (OR 0.10, 95%CI: 0.01-0.83; P = 0.034).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689674 | PMC |
| http://dx.doi.org/10.1002/acn3.50834 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Imaging biomarker associated with early neurological deterioration in isolated pontine infarction.
Front Neurol
December 2024
Department of Neurology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Objective: To investigate the association between cerebral small vessel disease burden, along with its individual imaging features, as well as other imaging features and early neurological deterioration in isolated pontine infarction.
Methods: 107 patients with acute isolated pontine infarcts, within 24 h of symptom onset, were retrospectively analyzed. The mean age of the participants was 67 years.
Prevalence and associations of cerebral microbleeds in an Australian memory clinic cohort.
Intern Med J
December 2024
Medical and Cognitive Research Unit, Department of Geriatric Medicine, Austin Health, Melbourne, Victoria, Australia.
Background: Cerebral microbleeds (CMBs) are small brain haemorrhages, identified by magnetic resonance imaging (MRI). They indicate potential for cognitive decline and mortality in memory clinic attendees. The presence of more than four CMBs is exclusionary for some clinical trials of disease-modifying therapies for Alzheimer's disease (AD).
View Article and Find Full Text PDFChanges in Cerebral Hemodynamics and Progression of Subclinical Vascular Brain Disease: A Population-Based Cohort Study.
Stroke
January 2025
Department of Epidemiology (D.B., F.J.W., A.H., M.A.I., M.W.V.), Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Article Synopsis
- Cerebral hypoperfusion, or reduced blood flow to the brain, may lead to brain injury and degeneration, but its long-term effects, especially in healthier older adults, are not well understood.
- This study tracked 3,623 healthy older adults over 11 years using brain scans to measure cerebral blood flow (CBF) and cerebrovascular resistance, aiming to examine changes in subclinical brain disease markers like white matter hyperintensities.
- Results showed that significant changes in CBF and increased cerebrovascular resistance were linked to a higher risk of progression in white matter hyperintensities, suggesting that monitoring blood flow can help identify potential brain health issues in older adults.
Obesity with low bone mineral density is a risk for cerebral small-vessel disease in older adults: The Bunkyo Health Study.
Obes Res Clin Pract
December 2024
Department of Metabolism & Endocrinology, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan; Sportology Center, Juntendo University Graduate School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Background: Cerebral small-vessel disease (cSVD), a key risk factor for stroke and dementia, has been linked to obesity and low bone mineral density (BMD). While obesity and low BMD are often inversely related, their coexistence may increase cSVD risk. We aimed to assess the prevalence of obesity and low BMD coexistence and its association with increased cSVD prevalence.
View Article and Find Full Text PDFNormative Population-Derived Data for MRI Manifestations of Cerebral Small Vessel Disease.
Stroke
December 2024
Departments of Radiology and Nuclear Medicine (M.W.V., E.E.B., E.J.V.), Erasmus MC, University Medical Centre, Rotterdam, the Netherlands.
Background: Cerebral small vessel disease (SVD) is manifested on magnetic resonance imaging (MRI) by white matter hyperintensities, lacunes, microbleeds, and atrophy. While these manifestations can be part of normal aging, a high burden has been associated with cognitive impairment and vascular events. Distinguishing between normal versus abnormal SVD lesion burden in clinical practice remains complex.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!